Effect of TenofovirDisoproxyl(TDF) on Hepatocellular Carcinoma (HCC) Incidence in Patients with Chronic Hepatitis B (CHB) Compared to Untreated Patients:A Multicenter Study with Propensity Score Matching (PSM)
AASLD - Presented at AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
MindieH. Nguyen1, Hwai-I Yang2, An K. Le1, NghiaH. Nguyen3, Jian Q. Zhang4, Chris Wong5, Clifford Wong5, HuyTrinh61. Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States2. Genomics Research Center, Academia Sinica, Taiwan, Taipei, Taiwan3. Internal Medicine, University of California, San Diego, San Diego, CA, United States4. Chinese Hospital, San Francisco, CA, United States5. Wong Clinics, San Francisco, CA, United States6. San Jose Gastroenterology, San Jose, CA, United States
This study was supported by an investigator-initiated grant to Stanford University by Gilead Sciences.